{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:29:04Z","timestamp":1769171344806,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T00:00:00Z","timestamp":1504137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009655","name":"Sunovion Pharmaceuticals Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009655","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Linda Townsend and Frances Weir of FireKite, an Ashfield company"},{"DOI":"10.13039\/100009655","name":"Sunovion Pharmaceuticals Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.rmed.2017.08.020","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T07:34:20Z","timestamp":1503560060000},"page":"251-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Long-term safety of glycopyrrolate\/eFlow\u00ae CS in moderate-to-very-severe COPD: Results from the Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer (GOLDEN) 5 randomized study"],"prefix":"10.1016","volume":"132","author":[{"given":"Gary T.","family":"Ferguson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Goodin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Tosiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Kerwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmed.2017.08.020_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1378\/chest.127.1.335","article-title":"Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians\/American College of Asthma, Allergy, and Immunology","volume":"127","author":"Dolovich","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2017.08.020_bib3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/COPD.S63485","article-title":"Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values","volume":"9","author":"Dal Negro","year":"2014","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"1","key":"10.1016\/j.rmed.2017.08.020_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13195-015-0116-3","article-title":"Lung disease as a determinant of cognitive decline and dementia","volume":"7","author":"Dodd","year":"2015","journal-title":"Alzheimers Res. Ther."},{"issue":"5\u20136","key":"10.1016\/j.rmed.2017.08.020_bib5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000091438","article-title":"Pulmonary function, cognitive impairment and brain atrophy in a middle-aged community sample","volume":"21","author":"Sachdev","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"5","key":"10.1016\/j.rmed.2017.08.020_bib6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jamaneurol.2014.94","article-title":"A\u00a0prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment","volume":"71","author":"Singh","year":"2014","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.rmed.2017.08.020_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4212\/cjhp.v65i2.1118","article-title":"Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease","volume":"65","author":"Batterink","year":"2012","journal-title":"Can. J. Hosp. Pharm."},{"issue":"3","key":"10.1016\/j.rmed.2017.08.020_bib8","first-page":"324","article-title":"Handling of inhaler devices in actual pulmonary practice: metered-dose inhaler versus dry powder inhalers","volume":"53","author":"Khassawneh","year":"2008","journal-title":"Respir. Care"},{"issue":"1","key":"10.1016\/j.rmed.2017.08.020_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000109374","article-title":"Dry powder inhalers: which factors determine the frequency of handling errors?","volume":"75","author":"Wieshammer","year":"2008","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.rmed.2017.08.020_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/089426803769017613","article-title":"Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care","volume":"16","author":"Molimard","year":"2003","journal-title":"J.\u00a0Aerosol Med."},{"issue":"10","key":"10.1016\/j.rmed.2017.08.020_bib11","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.arcped.2007.06.017","article-title":"Assessment of the handling of inhaler devices: an observational study of children in primary care","volume":"14","author":"Malot","year":"2007","journal-title":"Arch. Pediatr."},{"issue":"2","key":"10.1016\/j.rmed.2017.08.020_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afl174","article-title":"Inhaled therapy in elderly COPD patients; time re-evaluation?","volume":"36","author":"Jarvis","year":"2007","journal-title":"Age Ageing"},{"issue":"11","key":"10.1016\/j.rmed.2017.08.020_bib13","first-page":"641","article-title":"Inhaler devices for asthma and COPD: choice and technique","volume":"18","author":"Stevens","year":"2003","journal-title":"Prof. Nurse"},{"key":"10.1016\/j.rmed.2017.08.020_bib14","first-page":"23","article-title":"Considerations for managing chronic obstructive pulmonary disease in the elderly","volume":"9","author":"Taffet","year":"2014","journal-title":"Clin. Interv. Aging"},{"issue":"3","key":"10.1016\/j.rmed.2017.08.020_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/COPD.S3036","article-title":"Medication adherence issues in patients treated for COPD","volume":"3","author":"Restrepo","year":"2008","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"6","key":"10.1016\/j.rmed.2017.08.020_bib16","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1183\/09031936.00166410","article-title":"What the pulmonary specialist should know about the new inhalation therapies","volume":"37","author":"Laube","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2017.08.020_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/15412555.2011.630047","article-title":"The role of nebulized therapy in the management of COPD: evidence and recommendations","volume":"9","author":"Dhand","year":"2012","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2017.08.020_bib18","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.2147\/COPD.S114034","article-title":"A\u00a0review of nebulized drug delivery in COPD","volume":"11","author":"Tashkin","year":"2016","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"2","key":"10.1016\/j.rmed.2017.08.020_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/jamp.2013.1038","article-title":"Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate","volume":"27","author":"Mahler","year":"2014","journal-title":"J.\u00a0Aerosol Med. Pulm. Drug Deliv."},{"issue":"12","key":"10.1016\/j.rmed.2017.08.020_bib20","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.rmed.2013.07.001","article-title":"Long-term safety and efficacy of twice-daily aclidinium bromide in patients with COPD","volume":"107","author":"Gelb","year":"2013","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2017.08.020_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.rmed.2016.03.015","article-title":"Long-term safety of glycopyrrolate: a randomized study in patients with moderate-to-severe COPD (GEM3)","volume":"115","author":"Mahler","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2017.08.020_bib22","first-page":"A5472","article-title":"In-vitro characterization of the eFlow\u00ae Closed System (eFlow\u00ae CS) nebulizer with glycopyrrolate inhalation solution (SUN-101)","volume":"195","author":"Pham","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2017.08.020_bib23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/15412555.2012.761960","article-title":"Inhaler devices for patients with COPD","volume":"10","author":"Fink","year":"2013","journal-title":"COPD"},{"issue":"6","key":"10.1016\/j.rmed.2017.08.020_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/rmed.2001.1292","article-title":"Survey of patients' views of domiciliary nebuliser treatment for chronic lung disease","volume":"96","author":"Barta","year":"2002","journal-title":"Respir. Med."},{"issue":"7","key":"10.1016\/j.rmed.2017.08.020_bib25","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1513\/pats.200701-016FM","article-title":"Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators","volume":"4","author":"Hanania","year":"2007","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"4, Meeting abstracts","key":"10.1016\/j.rmed.2017.08.020_bib26","doi-asserted-by":"crossref","first-page":"68A","DOI":"10.1378\/chest.1990041","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of SUN-101 (glycopyrrolate inhalation solution) in subjects with moderate to severe COPD (GOLDEN 2)","volume":"146","author":"Kerwin","year":"2014","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2017.08.020_bib27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/bcp.12517","article-title":"Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease","volume":"79","author":"Leaker","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.rmed.2017.08.020_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2017.07.011","article-title":"Efficacy and safety of glycopyrrolate\/eFlow\u00ae CS (nebulized glycopyrrolate) in moderate-to-very-severe COPD: Results from the Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer (GOLDEN) 3 and 4 studies","author":"Kerwin","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2017.08.020_bib30","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH harmonised tripartite guideline: the extent of population exposure to assess clinical safety for drugs intended for long-term treatment of non-life-threatening conditions\u2014E1 (1994), Available from: http:\/\/academy.gmp-compliance.org\/guidemgr\/files\/E1_GUIDELINE.PDF (Accessed 30 June 2017)."},{"key":"10.1016\/j.rmed.2017.08.020_bib31","series-title":"Dose selection for glycopyrrolate\/eFlow\u00ae CS Phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) Phase II dose-finding studies","author":"Donohue","year":"2017"},{"issue":"2","key":"10.1016\/j.rmed.2017.08.020_bib32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/jam.2006.19.127","article-title":"Prescription bias and factors associated with improper use of inhalers","volume":"19","author":"Sestini","year":"2006","journal-title":"J.\u00a0Aerosol Med."},{"issue":"2","key":"10.1016\/j.rmed.2017.08.020_bib33","first-page":"174","article-title":"Performance comparison of nebulizer designs: Constant-output, breath-enhanced, and dosimetric","volume":"49","author":"Rau","year":"2004","journal-title":"Respir. Care"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117302901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117302901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:41:54Z","timestamp":1760614914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611117302901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":31,"alternative-id":["S0954611117302901"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2017.08.020","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term safety of glycopyrrolate\/eFlow\u00ae CS in moderate-to-very-severe COPD: Results from the Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer (GOLDEN) 5 randomized study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2017.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}